Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

How do urodynamics findings influence the treatment of the typical patient with overactive bladder?

Rutman MP, Cha DY, Blaivas JG.

Curr Urol Rep. 2012 Oct;13(5):370-8. doi: 10.1007/s11934-012-0265-x. Review.

PMID:
22843014
2.

Urodynamics in the evaluation of overactive bladder.

Rovner ES, Goudelocke CM.

Curr Urol Rep. 2010 Sep;11(5):343-7. doi: 10.1007/s11934-010-0130-8. Review.

PMID:
20585906
3.

Chapter 1: The conditions of neurogenic detrusor overactivity and overactive bladder.

Haab F.

Neurourol Urodyn. 2014 Jul;33 Suppl 3:S2-5. doi: 10.1002/nau.22636. Review.

PMID:
25042138
4.

Animal models in overactive bladder research.

Parsons BA, Drake MJ.

Handb Exp Pharmacol. 2011;(202):15-43. doi: 10.1007/978-3-642-16499-6_2. Review.

PMID:
21290220
5.

Overactive bladder symptoms and voiding dysfunction in neurologically normal women.

Espuña-Pons M, Cardozo L, Chapple C, Sievert KD, van Kerrebroeck P, Kirby MG.

Neurourol Urodyn. 2012 Apr;31(4):422-8. doi: 10.1002/nau.21252. Review.

PMID:
22419262
6.

Do patients with symptoms and signs of lower urinary tract dysfunction need a urodynamic diagnosis? ICI-RS 2013.

Rosier PF, Giarenis I, Valentini FA, Wein A, Cardozo L.

Neurourol Urodyn. 2014 Jun;33(5):581-6. doi: 10.1002/nau.22580. Review.

PMID:
24844430
7.

Pelvic organ prolapse and overactive bladder.

de Boer TA, Salvatore S, Cardozo L, Chapple C, Kelleher C, van Kerrebroeck P, Kirby MG, Koelbl H, Espuna-Pons M, Milsom I, Tubaro A, Wagg A, Vierhout ME.

Neurourol Urodyn. 2010;29(1):30-9. doi: 10.1002/nau.20858. Review.

PMID:
20025017
8.

Urgency assessment in the evaluation of overactive bladder (OAB).

Starkman JS, Dmochowski RR.

Neurourol Urodyn. 2008;27(1):13-21. Review.

PMID:
17671973
9.

Pediatric overactive bladder syndrome: pathophysiology and management.

Franco I.

Paediatr Drugs. 2007;9(6):379-90. Review.

PMID:
18052408
10.

Overactive bladder: diagnosis and management.

Robinson D, Cardozo L.

Maturitas. 2012 Feb;71(2):188-93. doi: 10.1016/j.maturitas.2011.11.016. Review.

PMID:
22197347
11.

[Pathophysiology of overactive bladder].

Juszczak K, Wyczółkowski M, Thor PJ.

Przegl Lek. 2010;67(7):488-90. Review. Polish.

PMID:
21387762
12.
13.

[Diagnostic and treatment of overactive bladder].

Nowara A, Witek A, Wilk K.

Ginekol Pol. 2007 Jul;78(7):549-53. Review. Polish.

PMID:
17915412
14.

Pharmacotherapy of overactive bladder: epidemiology and pathophysiology of overactive bladder.

Latini JM, Giannantoni A.

Expert Opin Pharmacother. 2011 May;12(7):1017-27. doi: 10.1517/14656566.2011.554396. Review.

PMID:
21473706
15.

Urgency: all or none phenomenon?

De Wachter S, Hanno P.

Neurourol Urodyn. 2010 Apr;29(4):616-7. doi: 10.1002/nau.20915. Review.

PMID:
20432323
16.

Considerations for the management of urgency symptoms in patients with overactive bladder syndrome.

Cardozo LD, Van Kerrebroeck PE, Staskin DR.

World J Urol. 2009 Dec;27(6):755-63. doi: 10.1007/s00345-009-0455-4. Review.

PMID:
19690868
17.

[Epidemiology and pathophysiology of overactive bladder].

Schumacher S.

Urologe A. 2006 Jul;45(7):822-5. Review. German.

PMID:
16758202
18.

Does the patient's position influence the detection of detrusor overactivity?

Al-Hayek S, Belal M, Abrams P.

Neurourol Urodyn. 2008;27(4):279-86. Review.

PMID:
17724734
19.

Pathophysiology of overactive bladder.

Banakhar MA, Al-Shaiji TF, Hassouna MM.

Int Urogynecol J. 2012 Aug;23(8):975-82. doi: 10.1007/s00192-012-1682-6. Review.

PMID:
22310925
20.

Current management and future perspectives of overactive bladder (OAB) pharmacotherapy.

Dobrek Ł, Juszczak K, Wyczółkowski M, Thor PJ.

Acta Pol Pharm. 2011 Nov-Dec;68(6):807-21. Review.

Items per page

Supplemental Content

Support Center